5′-terminal glycosylation of protein-coding transcripts: An epitranscriptomic modification that prolongs mRNA lifetimes
Proceedings of the National Academy of Sciences · 2025
DOI: 10.1073/pnas.2519788122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Tithi Banerjee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, New York University School of Medicine, New York, NY 10016. Hauptthemen laut MEDLINE: Escherichia coli, RNA, Messenger, RNA, Bacterial, Transcriptome. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, HHS | NIH | National Institute of General Medical Sciences (NIGMS).
Abstract (Originalsprache)
Glycosylation is among the most common molecular modifications in living organisms, one that affects the function of myriad macromolecules: mostly proteins, lipids, and polysaccharides of various kinds but also a few specific noncoding RNAs that undergo glycosylation at an internal site. Here we expand the glycome by showing that protein-coding transcripts can also be glycosylated, but in the form of a 5′-terminal glucose cap. These caps are present on up to 30 to 40% of the 5′ ends of U-initiated mRNAs in Escherichia coli , a remarkably high level of noncanonical capping that requires no transcript or promoter characteristic other than a 5′-terminal U. By contrast, no N -acetylglucosamine caps are evident. Due to their resistance to enzymatic removal, glucose caps can greatly prolong the cellular lifetime of mRNA by impeding its degradation via a 5′-end-dependent mechanism. The prevalence and protective impact of glucose caps set them apart from other bacterial RNA caps. This epitranscriptomic modification has the potential to selectively increase the synthesis of bacterial proteins encoded by U-initiated transcripts, especially after transcription is downregulated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, New York University School of Medicine, New York, NY 10016.
ORCID-Profile: Joel G Belasco
Förderung
- NIGMS NIH HHS
- HHS | NIH | National Institute of General Medical Sciences (NIGMS)
Zitieren
APA
Banerjee, T., Luciano, D. J., & Belasco, J. G. (2025). 5′-terminal glycosylation of protein-coding transcripts: An epitranscriptomic modification that prolongs mRNA lifetimes. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2519788122
Vancouver
Banerjee T, Luciano DJ, Belasco JG. 5′-terminal glycosylation of protein-coding transcripts: An epitranscriptomic modification that prolongs mRNA lifetimes. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2519788122
BibTeX
@article{Banerjee2025,
author = {Banerjee, Tithi and Luciano, Daniel J and Belasco, Joel G},
title = {5′-terminal glycosylation of protein-coding transcripts: An epitranscriptomic modification that prolongs mRNA lifetimes},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
doi = {10.1073/pnas.2519788122}
}
EUVIMED